Matthew R G Taylor

Title: Matthew R G Taylor: Innovator in Cardiovascular Treatment

Introduction

Matthew R G Taylor is a notable inventor based in Denver, Colorado. He has made significant contributions to the field of cardiovascular treatment through his innovative research and patented inventions. With a total of 2 patents, Taylor's work focuses on improving patient outcomes in heart conditions.

Latest Patents

One of Taylor's latest patents is centered around "Endothelin single nucleotide polymorphisms and methods of predicting β-adrenergic receptor targeting agent efficacy." This invention involves methods for evaluating the effectiveness of β-adrenergic receptor targeting agents in treating patients, particularly those with heart conditions. The methods include determining the presence or absence of polymorphisms in an endothelin gene system member. Based on these results, appropriate treatment regimens can be prescribed or altered, including the administration of β-blockers.

Career Highlights

Matthew R G Taylor is affiliated with the University of Colorado, where he continues to advance his research in cardiovascular health. His work has garnered attention for its potential to enhance treatment strategies for patients suffering from heart-related ailments.

Collaborations

Taylor collaborates with Luisa Mestroni, a fellow researcher in the field. Their combined expertise contributes to the development of innovative solutions for cardiovascular treatment.

Conclusion

Matthew R G Taylor's contributions to the field of cardiovascular treatment through his patents and research are noteworthy. His work aims to improve the efficacy of treatments for heart conditions, ultimately benefiting patient care.